Next-Generation Patient Monitoring Device Market Projected to Grow at 8.9% CAGR from 2022 to 2032

The latest research by Fact.MR on next-generation patient monitoring devices market provides in-depth insights into the key factors driving growth. It also examines the market across various segments, including product type, application, technology, and end user. The report presents a thorough analysis of the opportunities for expansion in both developed and emerging markets through 2032.

According to Fact.MR, a market research and competitive intelligence provider, the demand for next-generation patient monitoring devices is projected to grow at a healthy CAGR of 8.9% from 2022 to 2032. Currently valued at US$ 4.38 billion, the global market is expected to reach US$ 10.27 billion by 2032.

Remote monitoring technology in these devices allows for broader coverage in underserved regions, reducing treatment costs and travel time. This growth is driven by the increasing demand for monitoring devices that measure, record, and display various biometric data, such as blood oxygen levels, temperature, and blood pressure.

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐓𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭:- https://www.factmr.com/connectus/sample?flag=S&rep_id=567

Which Regions Lead Next-Gen Patient Monitoring Devices Market Growth?

North America holds a 26.3% share of the global next-generation patient monitoring devices market. The region leads the market due to its advanced healthcare infrastructure and the concentration of market players.

Europe, with a 21.5% market share, is the second-largest regional market for next-generation patient monitoring devices. The region's focus on patient care and high adoption rates are key factors driving market growth.

The Asia-Pacific excluding Japan (APEJ) region is expected to hold a significant share in the market during the forecast period, driven by the rise in chronic diseases and improvements in healthcare facilities. Japan also has a noteworthy market share due to its large elderly population and strong government support.

Competitive Landscape

Manufacturers of next-generation patient monitoring devices are continually advancing their manufacturing technologies to create innovative solutions, focusing on enhanced precision and cost-efficiency.

These providers are also partnering with healthcare professionals and various organizations to build networks and expand their sales potential.

For example, in 2020, Royal Philips, a global leader in health technology, introduced next-generation wearable biosensors designed to detect early signs of patient deterioration. This technology helps clinicians identify risks early, enabling timely interventions to improve patient outcomes in lower acuity care settings.

Key Segments Covered in Next Generation Patient Monitoring Devices Industry Research

• By Service :

  • MRI Compatible Devices
  • Non-MRI Compatible Devices

• By Component :

  • Wearable Components
  • Non-wearable Components

• By Application :

  • Diagnosis
  • Treatment Monitoring

• By End User :

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Diagnostic Centers
  • Home Care Settings

• By Region :

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Contact:

US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232
Email: sales@factmr.com